相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Comprehensive Review on Chemical Profiling of Nelumbo Nucifera: Potential for Drug Development
Bhesh Raj Sharma et al.
PHYTOTHERAPY RESEARCH (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Alkaloid rich fraction from Nelumbo nucifera targets VSMC proliferation and migration to suppress restenosis in balloon-injured rat carotid artery
Moon Young Jun et al.
ATHEROSCLEROSIS (2016)
Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses
Onat Kadioglu et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?
Nuggehally R. Srinivas
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Neferine induces autophagy of human ovarian cancer cells via p38 MAPK/ JNK activation
Limei Xu et al.
TUMOR BIOLOGY (2016)
Use of Second- and Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm
Elias Jabbour et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking
Mohamed Saeed et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Cytotoxicity of a naturally occurring furoquinoline alkaloid and four acridone alkaloids towards multi-factorial drug-resistant cancer cells
Victor Kuete et al.
PHYTOMEDICINE (2015)
Cytotoxicity of the indole alkaloid reserpine from Rauwoffia serpentina against drug-resistant tumor cells
Sara A. A. Abdelfatah et al.
PHYTOMEDICINE (2015)
Neferine, an alkaloid from lotus seed embryo, inhibits human lung cancer cell growth by MAPK activation and cell cycle arrest
Paramasivan Poornima et al.
BIOFACTORS (2014)
Resistance mechanisms of cancer cells to the novel vacuolar H+-ATPase inhibitor archazolid B
Rebecca Hamm et al.
INVESTIGATIONAL NEW DRUGS (2014)
The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein-a well-known, yet poorly understood drug transporter
Maen Zeino et al.
INVESTIGATIONAL NEW DRUGS (2014)
Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1
Yasuhiro Tajima et al.
PHYTOMEDICINE (2014)
Natural products: A continuing source of novel drug leads
Gordon M. Cragg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: Molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response
Jin-Soo Yoon et al.
PHYTOMEDICINE (2013)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Christopher A. Lipinski et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Collateral sensitivity as a strategy against cancer multidrug resistance
Kristen M. Pluchino et al.
DRUG RESISTANCE UPDATES (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II
Can Huang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells
Chenghui Huang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
Neferine increases STI571 chemosensitivity via inhibition of P-gp expression in STI571-resistant K562 cells
Qun Qin et al.
LEUKEMIA & LYMPHOMA (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Overcoming psychological barriers to good discovery decisions
Andrew T. Chadwick et al.
DRUG DISCOVERY TODAY (2010)
Gaussian Processes for Classification: QSAR Modeling of ADMET and Target Activity
Olga Obrezanova et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Making priors a priority
Matthew Segall et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Specificity in the Interaction of Natural Products with their Target Proteins- A Biochemical and Structural Insight
P. Venkatraman
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1
Daniel A. P. Gutmann et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil
Remi-Martin Laberge et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Stephen G. Aller et al.
SCIENCE (2009)
Second-line Therapy and Beyond Resistance for the Treatment of Patients With Chronic Myeloid Leukemia Post Imatinib Failure
Elias Jabbour et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Automatic QSAR modeling of ADME properties: blood-brain barrier penetration and aqueous solubility
Olga Obrezanova et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2008)
From traditional Chinese medicine to rational cancer therapy
Thomas Efferth et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
Jean-Pierre Gillet et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
hERG potassium channels and cardiac arrhythmia
MC Sanguinetti et al.
NATURE (2006)
The molecular basis of multidrug resistance in cancer: The early years of P-glycoprotein research
MM Gottesman et al.
FEBS LETTERS (2006)
A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia
KS Bauer et al.
LEUKEMIA RESEARCH (2005)
Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy
MA Summers et al.
ANNALS OF PHARMACOTHERAPY (2004)
分享论文
